MedPath

The impact of portal vein major circulation short-circuit embolization on the clinical course of the disease.

Not Applicable
Recruiting
Conditions
diffuse liver disease
Registration Number
JPRN-UMIN000052853
Lead Sponsor
Chiba University
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Recruiting
Sex
All
Target Recruitment
1000
Inclusion Criteria

Not provided

Exclusion Criteria

Patients who meet any of the following conditions are not eligible 1) Patients who are deemed by the investigator or subinvestigator to be unsuitable for the safe conduct of this study. 2) Patients who have expressed their refusal to participate in this study through a disclosure document. 3) Any other cases in which the safety of the patient may be compromised in the conduct of this study or in which it is deemed difficult to comply with the study protocol.

Study & Design

Study Type
Observational
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Comparison of overall survival within the study period with and without BRTO
Secondary Outcome Measures
NameTimeMethod
© Copyright 2025. All Rights Reserved by MedPath